scholarly journals Lower motor neuron facial palsy in a postnatal mother with COVID-19

2021 ◽  
Vol 14 (3) ◽  
pp. e240267
Author(s):  
Vignesh Kumar ◽  
Priyanka Narayanan ◽  
Seema Shetty ◽  
Afsal P Mohammed

COVID-19 is caused by the novel SARS-CoV-2 and is a potentially fatal disease that is of great global public health concern. In addition to respiratory symptoms, neurological manifestations have been associated with COVID-19. This is attributed to the neurotropic nature of coronaviruses. The authors present a case of Bell’s palsy associated with COVID-19 in a term primigravida.

Coronavirus disease (COVID-19) is caused by SARS-COV2 and represents the causative agent of a potentially fatal disease that is of great global public health concern [1-2]. Its involves humans as well as animals and may cause serious damage to the respiratory tract, including the lung: coronavirus disease (COVID-19). This pathogenic virus has been identified in swabs performed on the throat and nose of patients who suffer from or are suspected of the disease [1]. Based on the large number of infected people that were exposed to the wet animal market in Wuhan City, China, it is suggested that this is likely the zoonotic origin of COVID-19 [2].


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 977-982
Author(s):  
Mohamed J. Saadh ◽  
Bashar Haj Rashid M ◽  
Roa’a Matar ◽  
Sajeda Riyad Aldibs ◽  
Hala Sbaih ◽  
...  

SARS-COV2 virus causes Coronavirus disease (COVID-19) and represents the causative agent of a potentially fatal disease that is of great global public health concern. The novel coronavirus (2019) was discovered in 2019 in Wuhan, the market of the wet animal, China with viral pneumonia cases and is life-threatening. Today, WHO announces COVID-19 outbreak as a pandemic. COVID-19 is likely to be zoonotic. It is transmitted from bats as intermediary animals to human. Also, the virus is transmitted from human to human who is in close contact with others. The computerized tomographic chest scan is usually abnormal even in those with no symptoms or mild disease. Treatment is nearly supportive; the role of antiviral agents is yet to be established. The SARS-COV2 virus spreads faster than its two ancestors, the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower fatality. In this article, we aimed to summarize the transmission, symptoms, pathogenesis, diagnosis, treatment, and vaccine to control the spread of this fatal disease.


2020 ◽  
Vol 8 ◽  
Author(s):  
Bev John ◽  
Katy Holloway ◽  
Nyle Davies ◽  
Tom May ◽  
Marian Buhociu ◽  
...  

2019 ◽  
Vol 29 (2) ◽  
pp. 174-179 ◽  
Author(s):  
S. Mahmoudi ◽  
S. Agha Kuchak Afshari ◽  
S. Aghaei Gharehbolagh ◽  
H. Mirhendi ◽  
K. Makimura

PLoS Medicine ◽  
2016 ◽  
Vol 13 (4) ◽  
pp. e1002004 ◽  
Author(s):  
Delan Devakumar ◽  
David Osrin

2021 ◽  
Vol 11 (10) ◽  
pp. 961
Author(s):  
Ioannis Pantazopoulos ◽  
Stamatoula Tsikrika ◽  
Stavroula Kolokytha ◽  
Emmanouil Manos ◽  
Konstantinos Porpodis

COVID-19 is an emerging disease of global public health concern. As the pandemic overwhelmed emergency departments (EDs), a restructuring of emergency care delivery became necessary in many hospitals. Furthermore, with more than 2000 papers being published each week, keeping up with ever-changing information has proven to be difficult for emergency physicians. The aim of the present review is to provide emergency physician with a summary of the current literature regarding the management of COVID-19 patients in the emergency department.


2021 ◽  
Vol 14 (3) ◽  
pp. 379-382
Author(s):  
Adriana Morales-Moreno ◽  
José Carlos Ballena-López ◽  
Roxana Sandoval-Ahumada ◽  
Wilmer Silva-Caso ◽  
Giancarlo Pérez-Lazo

Background: Carbapenemase-producing Enterobacteriaceae (CPE) represents a global public health concern and systemic infections associated with OXA-48 carbapenemase are increasingly being reported in Latin America. Here, we present the first 2 cases of systemic infections by OXA-48-Producing Klebsiella pneumoniae in Peru. A favorable clinical response was observed after targeted treatment with colistin as a backbone.


Sign in / Sign up

Export Citation Format

Share Document